Angiogenic factors in the pathogenesis of preeclampsia (Q36339288)

13 August 2017

1 reference

title

Angiogenic factors in the pathogenesis of preeclampsia (English)

1 reference

13 August 2017

0 references

0 references

0 references

3

S Ananth Karumanchi

1 reference

13 August 2017

Hai-Tao Yuan

1

1 reference

PubMed ID

16344109

13 August 2017

David Haig

series ordinal

2

1 reference

13 August 2017

1 January 2005

1 reference

Current Topics in Developmental Biology

13 August 2017

1 reference

13 August 2017

71

1 reference

13 August 2017

297-312

1 reference

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Atrial natriuretic peptide (ANP) in preeclampsia-like syndrome in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Plasma endothelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Circulating levels of immunoreactive cytokines in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Risk factors for preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Vascular endothelial growth factor induces endothelial fenestrations in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Human cytotrophoblast invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Biochemical corroboration of endothelial involvement in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

A study of angiotensin II pressor response throughout primigravid pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Regulation of human placental development by oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Genetic conflicts in human pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Altercation of generations: genetic conflicts of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Selective fetocide reverses preeclampsia in discordant twins

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Elevated circulating thrombomodulin in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Trial of calcium to prevent preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Urinary Placental Growth Factor and Risk of Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Abnormal endothelial cell function of resistance arteries from women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Natural killer cells and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Endothelial dysfunction in preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Preeclampsia: what we know and what we do not know

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Pathogenesis and genetics of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Preeclampsia: an endothelial cell disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

The pathological response of the vessels of the placental bed to hypertensive pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

An instructive case of abdominal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

1 reference

7 January 2021

High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Parent-Offspring Conflict

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Pre-eclampsia and trisomy 13

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

1 reference

7 January 2021

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

The ultrastructure of acute atherosis in hypertensive pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0070-2153%2805%2971009-7

7 January 2021

10.1016/S0070-2153(05)71009-7

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16344109